West Pharmaceutical Services, Inc. WST
370.44
(3.16)
(0.85%)
as of 25 Sep
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 19.09% | 19.13% | 16.85% | 16.94% |
+8 more TTM periods Free account |
|
| 14.07% | 14.05% | 12.48% | 12.64% | ||
ROIC |
15.42% | 15.32% | 14.13% | 13.99% | |
Return on Tangible Assets |
19.80% | 19.01% | 16.19% | 16.79% | |
Average Days of Receivables |
78.12 | 77.69 | 68.20 | 75.59 | |
Free Cash Flow per Share |
6.17 | 6.36 | 6.49 | 5.25 | |
Free Cash Flow |
436.90 | 458.00 | 468.90 | 379.10 | |
Capital Expenditures |
(225.30) | (257.30) | (285.90) | (314.70) | |
Piotroski F-Score |
8.00 | 7.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
18.25% | 19.26% | 18.10% | 17.87% | |
Accounts Receivable Turnover |
5.14 | 5.24 | 5.46 | 5.25 | |
Accounts Payable Turnover |
8.55 | 8.54 | 7.99 | 8.10 | |
Inventory Turnover |
4.84 | 4.88 | 4.80 | 4.63 | |
Average Days of Payables |
43.86 | 44.87 | 47.00 | 48.02 | |
Days of Inventory on Hand |
77.65 | 80.49 | 82.24 | 82.23 | |
Tax Rate |
(0.21) | (0.21) | (0.20) | (0.21) | |
Research and Development Expense of Revenue |
2.24% | 2.29% | 2.42% | 2.35% | |
Selling, General and Administrative Expense of Revenue |
12.83% | 12.58% | 12.80% | 12.32% | |
Share Based Compensation of Revenue |
0.98% | 0.90% | 0.77% | 0.71% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.17 | 1.32 | 1.53 | 1.41 | |
Depreciation/Fixed assets |
0.11 | 0.10 | 0.10 | 0.09 | |
Capex/Depreciation |
(1.24) | (1.46) | (1.67) | (1.91) | |
Revenue per Share |
46.99 | 44.74 | 42.52 | 41.80 | |
Operating CF per Share |
9.35 | 9.93 | 10.44 | 9.61 | |
Capex per Share |
(3.18) | (3.57) | (3.95) | (4.36) | |
Capex to Sales |
0.07 | 0.08 | 0.09 | 0.10 | |
Net Profit Margin |
16.98% | 16.85% | 16.06% | 16.29% |
Columns are period end dates